webinar register page

ROTH Capital Healthcare Event - COVID-19 Therapeutics in Development - Oct 28, 2020 – 9:00 AM (ET) / 6:00 AM (PT)
ROTH Capital Partners’ Jonathan Aschoff, Ph.D., Tony Butler, Ph.D., Scott Henry, CFA, Zegbeh Jallah, Ph.D., and Elemer Piros, Ph.D., of our Healthcare & Biotechnology team are hosting a webinar to discuss key therapies in the development to treat COVID disease. Our event takes place on October 28, 2020, starting at 9:00 am (ET). The therapies to be discussed are often overlooked and are beyond those of Gilead, Regeneron or Lilly.

There has been an intense focus on the development of COVID-19 vaccines. Several vaccines may emerge by year-end-2020/early-2021, yet the logistics of mass vaccination remain a concern. Additionally, vaccines may not be 100% effective, mutations could overcome vaccine generated immunity, and some people will opt out of vaccination. While herd immunity is critical to overcoming SARS sequelae, therapies against COVID-19 remain important. Minimizing hospitalization, amelioration of COVID-19 disease, and reducing deaths are important contributors to moving us all back into a society of “mask-less” normalcy.

Our Webinar includes three sessions:

Session 1. 9:00-10:20 am (ET). Immune Modulators to Ameliorate COVID Disease 1
INmune Bio (INMB)
Ampio Pharmaceuticals (AMPE)
Humanigen (HGEN)
aTyr Pharma (LIFE)
Omeros (OMER)

Session 2. 10:30-11:50 am (ET). Direct Antivirals and Other Agents Against SARS-CoV2 Virus
Aridis Pharmaceuticals (ARDS)
Hepion Pharmaceuticals (HEPA)
Durect Corporation (DRRX)
CohBar Inc (CWBR)
Beyond Air (XAIR)
Tarek Hassanein, M.D., F.A.C.P., F.A.C.G., A.G.A.F., F.A.A.S.L.D., Professor of Medicine at University of California San Diego School of Medicine

Session 3. 12:00-1:20 pm (ET). Indirect Antivirals Against SARS-CoV2 Virus
Acer Therapeutics (ACER)
TFF Pharmaceuticals (TFFP)
Corvus Pharmaceuticals (CRVS)
Redhill Biopharma (RDHL)
Moleculin Biotech (MBRX)

(This is not an offer or solicitation of the securities herein.)

04:21:00

* Required information
Loading